Vir Biotechnology, Inc.(VIR)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

VIR Vir Biotechnology, Inc.

盘前交易 11-19 04:44:24 EST

7.03

-0.98

-12.23%

最高8.02	最低7.00	成交量225.14万
今开8.01	昨收8.01	日振幅12.73%
总市值9.68亿	流通市值6.50亿	总股本1.38亿
成交额1,656万	换手率2.43%	流通股本9,252万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"VIR","market":"US","secType":"STK","nameCN":"Vir Biotechnology, Inc.","latestPrice":7.03,"timestamp":1731963600000,"preClose":8.01,"halted":0,"volume":2251388,"delay":0,"floatShares":92515983,"shares":137720120,"eps":-3.934819,"marketStatus":"盘前交易","marketStatusCode":1,"change":-0.98,"latestTime":"11-19 04:44:24 EST","open":8.01,"high":8.02,"low":7,"amount":16561058.6095876,"amplitude":0.127341,"askPrice":10.98,"askSize":100,"bidPrice":7.17,"bidSize":200,"shortable":0,"etf":0,"ttmEps":-3.934819,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1732026600000},"adr":0,"listingDate":1570766400000,"adjPreClose":7.03,"postHourTrading":{"tag":"盘后","latestPrice":7.13,"preClose":7.03,"latestTime":"19:56 EST","volume":33236,"amount":238100.481,"timestamp":1731977806391},"volumeRatio":2.321296634110017,"impliedVol":1.416,"impliedVolPercentile":0.988},"requestUrl":"/m/hq/s/VIR","defaultTab":"news","newsList":[{"id":"2484476605","title":"Vir Biotechnology, Inc.盘中异动 快速下跌5.12%报7.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484476605","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484476605?lang=zh_cn&edition=full","pubTime":"2024-11-19 01:01","pubTimestamp":1731949289,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日01时01分，Vir Biotechnology, Inc.股票出现异动，股价快速下挫5.12%。Vir Biotechnology, Inc.股票所在的生物技术行业中，整体跌幅为0.06%。其相关个股中，Hcw Biologics Inc.、冠科美博、Exicure, Inc.涨幅较大，Hcw Biologics Inc.、Tharimmune, Inc.、冠科美博较为活跃，换手率分别为1021.46%、563.76%、544.65%，振幅较大的相关个股有Hcw Biologics Inc.、Apollomics Inc C/Wts 01/04/2028 、冠科美博，振幅分别为349.63%、129.51%、75.18%。Vir Biotechnology, Inc.公司简介：Vir Biotechnology Inc 是一家免疫学公司，专注于结合尖端技术治疗和预防严重传染病和其他严重疾病，包括病毒相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111901012998e43509&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111901012998e43509&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VIR","BK4585","BK4139","BK4568","BK4535"],"gpt_icon":0},{"id":"2483315033","title":"Vir Biotechnology, Inc.盘中异动 早盘急速跳水5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483315033","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483315033?lang=zh_cn&edition=full","pubTime":"2024-11-13 00:17","pubTimestamp":1731428256,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日00时17分，Vir Biotechnology, Inc.股票出现异动，股价大幅下挫5.07%。Vir Biotechnology, Inc.股票所在的生物技术行业中，整体跌幅为0.67%。Vir Biotechnology, Inc.公司简介：Vir Biotechnology Inc 是一家免疫学公司，专注于结合尖端技术治疗和预防严重传染病和其他严重疾病，包括病毒相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113001736a230f6ab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113001736a230f6ab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","VIR","BK4585","BK4568","BK4535"],"gpt_icon":0},{"id":"2482739782","title":"Vir Biotechnology, Inc.盘中异动 早盘急速拉升5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482739782","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482739782?lang=zh_cn&edition=full","pubTime":"2024-11-11 23:41","pubTimestamp":1731339718,"startTime":"0","endTime":"0","summary":"北京时间2024年11月11日23时41分，Vir Biotechnology, Inc.股票出现异动，股价大幅拉升5.16%。Vir Biotechnology, Inc.股票所在的生物技术行业中，整体跌幅为0.07%。Vir Biotechnology, Inc.公司简介：Vir Biotechnology Inc 是一家免疫学公司，专注于结合尖端技术治疗和预防严重传染病和其他严重疾病，包括病毒相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111123415898e41d5d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111123415898e41d5d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VIR","BK4585","BK4139","BK4568","BK4535"],"gpt_icon":0},{"id":"2482842213","title":"Vir Biotechnology, Inc.2024财年第三财季实现净利润-2.14亿美元，同比减少31.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482842213","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482842213?lang=zh_cn&edition=full","pubTime":"2024-11-10 00:00","pubTimestamp":1731168038,"startTime":"0","endTime":"0","summary":"11月10日，Vir Biotechnology, Inc.公布财报，公告显示公司2024财年第三财季净利润为-2.14亿美元，同比减少31.29%；其中营业收入为2.38百万美元，同比减少9.85%，每股基本收益为-1.56美元。机构评级：截至2024年11月10日，当前有8家机构对Vir Biotechnology, Inc.目标价做出预测，其中目标均价为29.88美元，其中最低目标价为10.00美元，最高目标价为110.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241110000057abb0ff7e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241110000057abb0ff7e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VIR"],"gpt_icon":0},{"id":"2481982772","title":"Vir Biotechnology, Inc.盘中异动 股价大涨5.19%报10.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481982772","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481982772?lang=zh_cn&edition=full","pubTime":"2024-11-06 23:47","pubTimestamp":1730908079,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日23时47分，Vir Biotechnology, Inc.股票出现异动，股价大幅拉升5.19%。Vir Biotechnology, Inc.股票所在的生物技术行业中，整体跌幅为0.80%。Vir Biotechnology, Inc.公司简介：Vir Biotechnology Inc 是一家免疫学公司，专注于结合尖端技术治疗和预防严重传染病和其他严重疾病，包括病毒相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106234800a21d57a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106234800a21d57a9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4535","VIR","BK4568","BK4139"],"gpt_icon":0},{"id":"1162759829","title":"异动解读 | 维尔生物技术股价大涨29.37% 分析师看好公司前景","url":"https://stock-news.laohu8.com/highlight/detail?id=1162759829","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1162759829?lang=zh_cn&edition=full","pubTime":"2024-11-02 15:38","pubTimestamp":1730533115,"startTime":"0","endTime":"0","summary":"11月1日,生物技术公司维尔生物技术股价创出29.37%的大涨行情,引发市场广泛关注。分析人士认为,维尔生物技术在行业良好氛围和自身布局的带动下,未来的发展前景广阔。这已引起多家机构对该股作出\"买入\"评级,投资者对公司长远前景持乐观态度,大量资金流入催生了当日的大涨行情。同时,生物技术行业整体向好,也助推了维尔生物技术股价上涨。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["VIR"],"gpt_icon":0},{"id":"1125509414","title":"异动解读 | 维尔生物技术公司股价大涨29% 分析师看好公司前景","url":"https://stock-news.laohu8.com/highlight/detail?id=1125509414","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1125509414?lang=zh_cn&edition=full","pubTime":"2024-11-02 05:12","pubTimestamp":1730495567,"startTime":"0","endTime":"0","summary":"生物技术公司维尔生物技术今日股价大涨29.37%,引发市场广泛关注。分析人士认为,在公司业绩逐步改善以及重要产品线前景广阔的预期下,该股获得机构认可和资金青睐,推动股价出现大幅上涨。此外,在良好的行业氛围和布局前景下,多家机构给予维尔生物技术股\"买入\"评级,认为公司具备长期增长潜力,这有助于吸引更多资金流入。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["VIR"],"gpt_icon":0},{"id":"1120302931","title":"异动解读 | 生物技术公司Vir股价大涨8.67% 可能受业绩好转和行业氛围影响","url":"https://stock-news.laohu8.com/highlight/detail?id=1120302931","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1120302931?lang=zh_cn&edition=full","pubTime":"2024-11-01 21:43","pubTimestamp":1730468601,"startTime":"0","endTime":"0","summary":"生物技术公司Vir Biotechnology, Inc.今日股价大涨8.67%,引发市场关注。从公开资料来看,公司最新财报虽然仍处于亏损状态,但营收数据有所改善,加之公司在重要疾病领域拥有潜力产品线,获得机构普遍\"买入\"评级。此外,整个生物技术行业当日表现向好,板块整体上涨0.32%,良好的行业氛围也可能带动了Vir Biotechnology股价攀升。总的来说,市场预期该公司业绩将继续改善,加之行业形势利好,为Vir股价上涨提供了支撑。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["VIR"],"gpt_icon":0},{"id":"2480886973","title":"Vir Biotechnology, Inc.盘中异动 股价大涨5.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480886973","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480886973?lang=zh_cn&edition=full","pubTime":"2024-11-01 21:35","pubTimestamp":1730468139,"startTime":"0","endTime":"0","summary":"北京时间2024年11月01日21时35分，Vir Biotechnology, Inc.股票出现异动，股价快速拉升5.47%。Vir Biotechnology, Inc.股票所在的生物技术行业中，整体涨幅为0.32%。其相关个股中，Tc Biopharm  Plc C/Wts 10/02/2028 、Klotho Neurosciences Inc C/Wts 21/06/2029 、Theriva Biologics, Inc.涨幅较大，Theriva Biologics, Inc.、Athira Pharma, Inc.、Elevai Labs, Inc.较为活跃，换手率分别为1747.38%、129.71%、80.41%，振幅较大的相关个股有Theriva Biologics, Inc.、Cyclerion Therapeutics, Inc.、Mesoblast Ltd，振幅分别为36.30%、19.38%、18.08%。Vir Biotechnology, Inc.公司简介：Vir Biotechnology Inc 是一家免疫学公司，专注于结合尖端技术治疗和预防严重传染病和其他严重疾病，包括病毒相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110121353998e3fff5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110121353998e3fff5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VIR","BK4568","BK4139","BK4585","BK4535"],"gpt_icon":0},{"id":"2480041890","title":"维尔生物技术公司公布截至 1 月 1 日的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2480041890","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480041890?lang=zh_cn&edition=full","pubTime":"2024-11-01 11:34","pubTimestamp":1730432086,"startTime":"0","endTime":"0","summary":"维尔生物技术公司公布截至 1 月 1 日的季度业绩 - 收益摘要Vir Biotechnology Inc VIR.OQ报告了截至1月1日的季度调整后每股亏损1.56美元，低于去年同期的每股收益1.22美元。华尔街预期为每股亏损 1.75 美元至-85 美分。Vir 生物技术公司公布的本季度每股收益为亏损 1.56 美元。该公司一季度亏损 2.1372 亿美元。Vir Biotechnology Inc 本季度股价上涨了 1.5%，今年迄今为止亏损了 24.5%。生物技术和医学研究同行的平均一致建议也是 \"买入\"。华尔街对 Vir 生物技术公司 12 个月目标价的中位数为 21.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241101:nL4T3M80GF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","VIR","BK4568","BK4535","BK4139"],"gpt_icon":0},{"id":"2478348980","title":"Vir Biotechnology, Inc.盘中异动 大幅上涨5.08%报7.86美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478348980","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478348980?lang=zh_cn&edition=full","pubTime":"2024-10-28 21:51","pubTimestamp":1730123507,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日21时51分，Vir Biotechnology, Inc.股票出现异动，股价大幅拉升5.08%。Vir Biotechnology, Inc.股票所在的生物技术行业中，整体涨幅为0.66%。Vir Biotechnology, Inc.公司简介：Vir Biotechnology Inc 是一家免疫学公司，专注于结合尖端技术治疗和预防严重传染病和其他严重疾病，包括病毒相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102821514898e3ed3a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102821514898e3ed3a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4568","BK4139","VIR","BK4535"],"gpt_icon":0},{"id":"2478956964","title":"Vir Biotechnology, Inc.盘中异动 急速上涨5.44%报7.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478956964","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478956964?lang=zh_cn&edition=full","pubTime":"2024-10-26 00:23","pubTimestamp":1729873404,"startTime":"0","endTime":"0","summary":"北京时间2024年10月26日00时23分，Vir Biotechnology, Inc.股票出现异动，股价大幅拉升5.44%。Vir Biotechnology, Inc.股票所在的生物技术行业中，整体涨幅为0.82%。其相关个股中，Iterum Therapeutics Plc、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Immunitybio, Inc.涨幅较大，180 Life Sciences Corp.、Elevai Labs, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为830.51%、750.70%、243.31%，振幅较大的相关个股有Iterum Therapeutics Plc、Qualigen Therapeutics, Inc.、Elevai Labs, Inc.，振幅分别为100.75%、91.58%、85.68%。Vir Biotechnology, Inc.公司简介：Vir Biotechnology Inc 是一家免疫学公司，专注于结合尖端技术治疗和预防严重传染病和其他严重疾病，包括病毒相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102600232498e3e8cc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102600232498e3e8cc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4535","VIR","BK4568","BK4139"],"gpt_icon":0},{"id":"2473748250","title":"Vir Biotechnology, Inc.盘中异动 下午盘快速下跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2473748250","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473748250?lang=zh_cn&edition=full","pubTime":"2024-10-08 02:30","pubTimestamp":1728325821,"startTime":"0","endTime":"0","summary":"北京时间2024年10月08日02时30分，Vir Biotechnology, Inc.股票出现波动，股价急速下跌5.04%。Vir Biotechnology, Inc.股票所在的生物技术行业中，整体跌幅为0.09%。Vir Biotechnology, Inc.公司简介：Vir Biotechnology Inc 是一家免疫学公司，专注于结合尖端技术治疗和预防严重传染病和其他严重疾病，包括病毒相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410080230219719eb49&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410080230219719eb49&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4568","BK4535","BK4139","VIR"],"gpt_icon":0},{"id":"2473967901","title":"Vir Biotechnology, Inc.盘中异动 股价大涨5.05%报7.70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2473967901","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473967901?lang=zh_cn&edition=full","pubTime":"2024-10-05 00:49","pubTimestamp":1728060594,"startTime":"0","endTime":"0","summary":"北京时间2024年10月05日00时49分，Vir Biotechnology, Inc.股票出现异动，股价大幅上涨5.05%。截至发稿，该股报7.70美元/股，成交量19.4914万股，换手率0.14%，振幅4.23%。Vir Biotechnology, Inc.股票所在的生物技术行业中，整体跌幅为0.09%。Vir Biotechnology, Inc.公司简介：Vir Biotechnology Inc 是一家免疫学公司，专注于结合尖端技术治疗和预防严重传染病和其他严重疾病，包括病毒相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100500495598e3aa44&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100500495598e3aa44&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4535","VIR","BK4568","BK4139"],"gpt_icon":0},{"id":"2458844616","title":"Vir Biotechnology, Inc.2024财年第二财季实现净利润-1.38亿美元，同比增加29.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458844616","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458844616?lang=zh_cn&edition=full","pubTime":"2024-08-11 00:14","pubTimestamp":1723306488,"startTime":"0","endTime":"0","summary":"8月11日，Vir Biotechnology, Inc.公布财报，公告显示公司2024财年第二财季净利润为-1.38亿美元，同比增加29.23%；其中营业收入为3.08百万美元，同比减少18.95%，每股基本收益为-1.02美元。机构评级：截至2024年8月11日，当前有8家机构对Vir Biotechnology, Inc.目标价做出预测，其中目标均价为31.25美元，其中最低目标价为13.00美元，最高目标价为110.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240811001450958e71ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240811001450958e71ae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VIR"],"gpt_icon":0},{"id":"2457775044","title":"Vir Biotechnology, Inc.盘中异动 早盘快速下跌6.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457775044","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457775044?lang=zh_cn&edition=full","pubTime":"2024-08-05 21:42","pubTimestamp":1722865346,"startTime":"0","endTime":"0","summary":"北京时间2024年08月05日21时42分，Vir Biotechnology, Inc.股票出现异动，股价大幅跳水6.08%。Vir Biotechnology, Inc.股票所在的生物技术行业中，整体跌幅为2.13%。Vir Biotechnology, Inc.公司简介：Vir Biotechnology Inc 是一家免疫学公司，专注于结合尖端技术治疗和预防严重传染病和其他严重疾病，包括病毒相关疾病。消息层面，截至21时42分，Vir Biotechnology, Inc.股票正面舆情新闻比例33.33%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408052142269f1075e0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408052142269f1075e0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4585","BK4535","VIR","BK4568"],"gpt_icon":0},{"id":"2456849863","title":"维尔生物技术公司公布截至 6 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2456849863","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456849863?lang=zh_cn&edition=full","pubTime":"2024-08-02 05:37","pubTimestamp":1722548251,"startTime":"0","endTime":"0","summary":"   * Vir Biotechnology Inc   报告，截至6月底的季度调整后每股亏损1.02美元，高于去年同期的每股亏损1.45美元。八位分析师对该季度的平均预期是每股亏损 90 美分。华尔街预期为每股亏损 1.10 美元至-54 美分。* Vir 生物技术公司公布的本季度每股收益为亏损 1.02 美元。* Vir Biotechnology Inc 本季度股价上涨了 14.2%，今年迄今为止上涨了 1.0%。* 生物技术和医学研究同行的平均一致建议也是 \"买入\"。华尔街对 Vir 生物技术公司 12 个月目标价的中位数为 20.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4535","BK4568","VIR","BK4585"],"gpt_icon":0},{"id":"2456465505","title":"Vir Biotechnology, Inc.盘中异动 下午盘股价大跌5.02%报9.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2456465505","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456465505?lang=zh_cn&edition=full","pubTime":"2024-08-02 03:07","pubTimestamp":1722539263,"startTime":"0","endTime":"0","summary":"北京时间2024年08月02日03时07分，Vir Biotechnology, Inc.股票出现波动，股价急速跳水5.02%。截至发稿，该股报9.65美元/股，成交量61.0598万股，换手率0.45%，振幅4.38%。Vir Biotechnology, Inc.股票所在的生物技术行业中，整体涨幅为0.73%。Vir Biotechnology, Inc.公司简介：Vir Biotechnology Inc 是一家免疫学公司，专注于结合尖端技术治疗和预防严重传染病和其他严重疾病，包括病毒相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802030744af9567cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802030744af9567cd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4535","VIR","BK4568","BK4139"],"gpt_icon":0},{"id":"2455996047","title":"维尔生物技术公司    预计每股亏损 90 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2455996047","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455996047?lang=zh_cn&edition=full","pubTime":"2024-07-31 04:54","pubTimestamp":1722372881,"startTime":"0","endTime":"0","summary":"   * 维尔生物技术公司   预计在8月1日公布截至0001年1月1日的业绩时，季度收入将出现增长。* 根据LSEG的数据，6位分析师的平均预期显示，这家总部位于加利福尼亚州旧金山的公司的营收预计将从去年同期的380万美元增长97.4%，达到749.7万美元。* LSEG分析师对Vir Biotechnology Inc的平均预期是每股亏损90美分。* 华尔街对 Vir Biotechnology Inc 的 12 个月目标价中位数为 20.00 美元，高于其上次收盘价 10.50 美元。7月30日 - 上一季度业绩。除非另有说明，所有数字均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VIR"],"gpt_icon":0},{"id":"2454872677","title":"Vir Biotechnology, Inc.盘中异动 股价大涨5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2454872677","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454872677?lang=zh_cn&edition=full","pubTime":"2024-07-25 22:15","pubTimestamp":1721916946,"startTime":"0","endTime":"0","summary":"北京时间2024年07月25日22时15分，Vir Biotechnology, Inc.股票出现波动，股价大幅上涨5.15%。Vir Biotechnology, Inc.股票所在的生物技术行业中，整体涨幅为0.84%。Vir Biotechnology, Inc.公司简介：Vir Biotechnology Inc 是一家免疫学公司，专注于结合尖端技术治疗和预防严重传染病和其他严重疾病，包括病毒相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240725221546941faa2b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240725221546941faa2b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4535","BK4139","BK4568","BK4585","VIR"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.vir.bio","stockEarnings":[{"period":"1week","weight":-0.2877},{"period":"1month","weight":-0.0786},{"period":"3month","weight":-0.202},{"period":"6month","weight":-0.3817},{"period":"1year","weight":-0.2745},{"period":"ytd","weight":-0.3012}],"compareEarnings":[{"period":"1week","weight":-0.0177},{"period":"1month","weight":0.0061},{"period":"3month","weight":0.0527},{"period":"6month","weight":0.1101},{"period":"1year","weight":0.3047},{"period":"ytd","weight":0.2374}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Vir Biotechnology, Inc.于2016年4月7日根据特拉华州法律注册成立。该公司是一家免疫学公司，专注于结合前沿技术来治疗和预防严重传染病和其他严重疾病，包括病毒相关疾病。该公司的目标是通过两种基本方式实现这一目标——第一，通过开发强大的抗体疗法，第二，通过基于T细胞的病毒载体平台在体内产生独特的T细胞反应。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.489907},{"month":2,"riseRate":0.4,"avgChangeRate":0.083527},{"month":3,"riseRate":0.4,"avgChangeRate":-0.100299},{"month":4,"riseRate":0.2,"avgChangeRate":-0.094284},{"month":5,"riseRate":0.8,"avgChangeRate":0.108172},{"month":6,"riseRate":0.4,"avgChangeRate":0.019995},{"month":7,"riseRate":0.6,"avgChangeRate":-0.054563},{"month":8,"riseRate":0.2,"avgChangeRate":-0.028112},{"month":9,"riseRate":0,"avgChangeRate":-0.169768},{"month":10,"riseRate":0.2,"avgChangeRate":-0.046173},{"month":11,"riseRate":0.666667,"avgChangeRate":0.08959},{"month":12,"riseRate":0.4,"avgChangeRate":-0.053554}],"exchange":"NASDAQ","name":"Vir Biotechnology, Inc.","nameEN":"Vir Biotechnology, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Vir Biotechnology, Inc.(VIR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Vir Biotechnology, Inc.(VIR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Vir Biotechnology, Inc.,VIR,Vir Biotechnology, Inc.股票,Vir Biotechnology, Inc.股票老虎,Vir Biotechnology, Inc.股票老虎国际,Vir Biotechnology, Inc.行情,Vir Biotechnology, Inc.股票行情,Vir Biotechnology, Inc.股价,Vir Biotechnology, Inc.股市,Vir Biotechnology, Inc.股票价格,Vir Biotechnology, Inc.股票交易,Vir Biotechnology, Inc.股票购买,Vir Biotechnology, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Vir Biotechnology, Inc.(VIR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Vir Biotechnology, Inc.(VIR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}